JPH0665297A - メラニン合成抑制蛋白質とその製造方法並びに用途 - Google Patents

メラニン合成抑制蛋白質とその製造方法並びに用途

Info

Publication number
JPH0665297A
JPH0665297A JP4264025A JP26402592A JPH0665297A JP H0665297 A JPH0665297 A JP H0665297A JP 4264025 A JP4264025 A JP 4264025A JP 26402592 A JP26402592 A JP 26402592A JP H0665297 A JPH0665297 A JP H0665297A
Authority
JP
Japan
Prior art keywords
protein
melanin synthesis
activity
cells
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4264025A
Other languages
English (en)
Japanese (ja)
Inventor
Yoshiatsu Fukuda
恵温 福田
Yasuo Suemoto
保雄 末本
Masashi Kurimoto
雅司 栗本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Biochemical Laboratories Co Ltd
Priority to JP4264025A priority Critical patent/JPH0665297A/ja
Priority to CA002104043A priority patent/CA2104043A1/en
Priority to TW082106557A priority patent/TW267171B/zh
Priority to KR1019930016084A priority patent/KR940003968A/ko
Priority to EP93306618A priority patent/EP0586154A3/en
Priority to US08/109,249 priority patent/US5331091A/en
Publication of JPH0665297A publication Critical patent/JPH0665297A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP4264025A 1992-08-21 1992-08-21 メラニン合成抑制蛋白質とその製造方法並びに用途 Pending JPH0665297A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP4264025A JPH0665297A (ja) 1992-08-21 1992-08-21 メラニン合成抑制蛋白質とその製造方法並びに用途
CA002104043A CA2104043A1 (en) 1992-08-21 1993-08-13 Melanin formation-inhibitory protein, and its preparation and uses
TW082106557A TW267171B (2) 1992-08-21 1993-08-16
KR1019930016084A KR940003968A (ko) 1992-08-21 1993-08-19 멜라닌 합성 억제 단백질과 그 제조 방법 및 그 용도
EP93306618A EP0586154A3 (en) 1992-08-21 1993-08-20 Melanin-inhibiting protein, its production and applications.
US08/109,249 US5331091A (en) 1992-08-21 1993-08-20 Melanin formation-inhibitory protein, and its preparation and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4264025A JPH0665297A (ja) 1992-08-21 1992-08-21 メラニン合成抑制蛋白質とその製造方法並びに用途

Publications (1)

Publication Number Publication Date
JPH0665297A true JPH0665297A (ja) 1994-03-08

Family

ID=17397510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4264025A Pending JPH0665297A (ja) 1992-08-21 1992-08-21 メラニン合成抑制蛋白質とその製造方法並びに用途

Country Status (6)

Country Link
US (1) US5331091A (2)
EP (1) EP0586154A3 (2)
JP (1) JPH0665297A (2)
KR (1) KR940003968A (2)
CA (1) CA2104043A1 (2)
TW (1) TW267171B (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719126A (en) * 1992-11-24 1998-02-17 University Of Cincinnati Melanogenic inhibitor, and methods of producing and using the same
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
GB9719195D0 (en) * 1997-09-09 1997-11-12 Unilever Plc Skin lightening composition
WO2002087530A1 (en) * 2001-04-27 2002-11-07 The General Hospital Corporation Tyrosinase assay
US20080070982A1 (en) * 2006-09-15 2008-03-20 Graham Timmins System and methods of melanoma prevention
CN118894928B (zh) * 2024-07-11 2025-04-25 西安巨子生物基因技术股份有限公司 I型重组胶原蛋白、其金属螯合物及美白化妆品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5654158A (en) * 1979-10-09 1981-05-14 Hitachi Ltd Control system for call waiting
JPH01174389A (ja) * 1987-12-29 1989-07-10 Hayashibara Biochem Lab Inc メラニン生成抑制物質の製造方法とそれを含有する色白剤
DE69004242T2 (de) * 1990-01-23 1994-05-05 Morinaga Milk Industry Co Ltd Laktoferrinhydrolysat zur Verwendung als antibakterielles Mittel.

Also Published As

Publication number Publication date
CA2104043A1 (en) 1994-02-22
KR940003968A (ko) 1994-03-14
EP0586154A3 (en) 1995-01-18
TW267171B (2) 1996-01-01
EP0586154A2 (en) 1994-03-09
US5331091A (en) 1994-07-19

Similar Documents

Publication Publication Date Title
JP3819603B2 (ja) 表皮から単離されたポリペプチドとその用途
RU2181292C2 (ru) Экстракты акульего хряща, обладающие противоколлагенолитическим, противовоспалительным, антиангиогенным и противоопухолевым действием, способ получения, способы применения и содержащие их композиции
JP3843943B2 (ja) Ｎ−アシルアミノ−アミドファミリーの新規な化合物、それを含有する組成物及び用途
EP2280064A2 (en) Composition comprising vegetable peptone for promoting stem cell proliferation
JPH08231370A (ja) 皮膚化粧料
AU2014217461A1 (en) Composition for cosmetic use suitable to produce a pigmentation effect on hair
CN104024271B (zh) 基质金属蛋白酶活性抑制肽及其用途
Chang et al. Expression of nitric oxide synthases in keratinocytes after UVB irradiation
JP4441123B2 (ja) 加齢皮膚の徴候を処置するための組成物におけるロスマリヌス属の植物抽出物の使用
US20050142081A1 (en) Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least on matrix metalloproteinase inhibitor
KR101848887B1 (ko) 피부 미백 활성을 가지는 트라넥삼산-펩타이드 및 그 용도
IMOKAWA et al. Biochemical characterization of tyrosinase inhibitors using tyrosinase binding affinity chromatography
JPH0665297A (ja) メラニン合成抑制蛋白質とその製造方法並びに用途
JP2003063984A (ja) Ｎ−アシルアミノアミドファミリーのエラスターゼ阻害剤と少なくとも１種の抗真菌剤又は少なくとも１種の抗菌剤の組み合わせを含む化粧品用又は皮膚用組成物
US20060216253A1 (en) Whitening cosmetics containing morus alba extracts
JPH01174389A (ja) メラニン生成抑制物質の製造方法とそれを含有する色白剤
BRPI0617938A2 (pt) utilização de uma quantidade eficaz de pelo menos uma substáncia modulando a expressão e/ou atividade de lox e de um anticorpo anti-nrage, métodos de utilização e de identificação de pelo menos um princìpio ativo destinado a modular a interação entre lox e nrage e de localização de nrage e processo de preparação de uma composição
US20080119558A1 (en) Drug for Inhibiting Production of Matrix Metalloprotease-9
US5719126A (en) Melanogenic inhibitor, and methods of producing and using the same
JPS638310A (ja) メラニン生成抑制外用薬剤
JP2003267882A (ja) 皮膚化粧料
JPH01207225A (ja) 毛髪化粧料
Yang et al. Furocoumarin from radix angelica dahurica and synthetic analogue as potential agent for treatment of vitiligo
RU2847265C2 (ru) Производное тетрапептида, косметическая композиция или фармацевтическая композиция и их применение
JP3231898B2 (ja) 美白化粧料